A

LIVE PROJECT REPORT

ON

YACCA PHARMACEUTICALS PVT. LTD.

SUBMITTED BY

SHALU PAL

SUBMITTED TO

ANITA BHANDARI

FOR

PARTIAL FULFILMENT OF THE DEGREE

OF

MASTER OF BUSINESS ADMINISTRATION

UTTRAKHAND TECHNICAL UNIVERSITY

DEHRADUN

PINCODE:- 248001

SESSION :- 2018-2020
 DECLARATION

I, The undersigned , hereby declared that the Live project report entitled

“ MANUFACTURING AND PRODUCTION ” submitted by me to the university in the partial

fulfillment of the requirement for the award of degree of MBA (MASTER OF BUSINESS
ADMINISTRATION ) under the guidance of “ ANITA BHANDARI MAM ” is my original
work & the conclusion drawn therein are based on the material/data collected by myself.

The report submitted is my own work & hence not from any other source.

I shall be responsible for any unpleasure moment/situation (if any)

 GUIDE CERTIFICATE

This is to certify that SHALU PAL is the bonafied student of MBA have successfully completed
the project work as described by the university in the partial fulfillment of the MBA ( MASTER
OF BUSINESS ADMINISTRATION ) of the academic year 2018-19.

The project work entitled as “ MANUFACTURING AND PRODUCTION ”

Project guide - ANITA BHANDARI

Signature
 ACKNOWLEDGEMENT

A successful project is the result of team work & coordination that includes not only the group of
developers who put for the ideas, logics but also those who guide them. So, at the completion of
the project I feel obliged to extent my gratitude towards all those who made valuable conclusions
throughout my research period.

I am thankful for all the knowledge/guidance & support imparted by “ ANITA BHANDARI
MAM ” to me who gave me invaluable knowledge in the period.

In addition I wish to convey deep sense of gratitude towards “hod name” at any time. I needed.

At the end just as significantly, I would like to express my sincere thanks to management
department & all the other members who have provided me excellent knowledge & guidance
throughout my MBA degree.
 INDEX

CONTENT PAGE NO.

 INTRODUCTION OF THE COMPANY ………………………………….1
 OBJECTIVES ……………………………………………………….1
 MISSION & VISION ……………………………………………….1
 COMPANY OWNERSHIP ………………………………………….1
 KEYS TO SUCCESS……………………………………………..….1
 START-UP COSTS & FUNDING ………………………………….2
 PRODUCT AND SERVICES ……………………………………….2
 RESERCH METHODOLOGY
 DATA ANALYSIS AND INTERPRETATION
 FINDINGS
 SIGNIFICANCE OF THE STUDY
 LIMITATION OF THE STUDY
 RECOMMENDATION
 CONCLUSION
 QUESTIONAIR
 BIBLOGRAPHI
INTRODUCTION OF THE COMPANY

YACCA PHARMACUTICALS PVT. LTD .

YACCA came into existence in the year 1992, under

the Leadership of our Chairman - Mr. P.K.BANSAL .

Ever since then it is achieving new heights every single day. The sole motive and vision of the
company is to avail medicine and healthcare facilities to maximum people throughout the globe.

YACCA has established and proved its name to its customers and clients in terms of QUALITY
PRODUCTS, ON TIME DELIVERY, and COMPETITIVE RATES.

Quality Products -

A highly experienced team has been assigned which looks after all the manufacturing
operations in the plants to ensure that the word “quality” proves its meaning in the market.

On-time delivery -

Being a Third party manufacturing company we understand the importance of time

punctuality amongst our services.

Competitive Rates -

We offer very competitive rates due to a highly energy efficient plant, competitive raw
material and packaging material purchases. We believe it is our responsibility to offer
competitive rates so that Yacca and its customers grow together.

All the above has been achieved due to the presence of a team which understands their
responsibilities, ultra-modern plants that have been designed keeping international
standards in mind and the involvement of our chairman himself whose experience and
knowledge ensures that every formulation leaving our company proves its effectiveness to
the end customer.

At YACCA commitments and promises are made with the confidence that they will never
be broken.
 COMPANY PROFILE

YACCA PHARMACUTICALS PVT. LTD

 FOUNDED & OWNER :- MR. P.K. BANSAL

 ESTIBLISHED :- 1992
 HEAD OFFICE :- BHAGWANPUR , DEHRADUN ROAD
 INDUSTRY :- MEDICAL SERVICES
 PRODUTS:- Tablets (β-Lactam & Non β-Lactam), Capsules (β-Lactam & Non β-
Lactam), Syrups, Ointments and External Lotion
 STARTED CAPITAL :- 10 LACS
 EMPLOYEES :- 80 PERSON
 WEBSITE :- info@yaccapharma.com
www.yaccapharma.com
Introduction to Pharma Industry :

Drug abuse is becoming a serious problem in India. Thanks to the easy availability of
various addictive substances and inadequate control, drug abuse has assumed an alarming
proportion both in the urban and rural areas. Fast-growing unemployment in rural India
and the outgoing personality of the average Indian have given a boost to the problem.
Many research workers, social scientists and religious organisations have been regularly
pointing towards the rising incidence of alcohol and drug abuse.
My project report is based on Analytical and Survey Study through questionnaire. The
study deals with the comparative study of various Pharmaceutical Companies that deals in
manufacturing commonly used drugs like Antibiotics, Antifungal, Topical Steroids etc.
The study is related to study their average sales in comparison with each other, their
schemes and brand loyalty of customer.
Besides the study also gives graphical representation for these companies based on the
information gathered from some of the dealers chosen for this very study.

Pharmaceutical Industry : An Introduction

Pharmaceuticals are medicinally effective chemicals, which are converted to dosage forms
suitable for patients to imbibe. In its basic chemical form, pharmaceuticals are called bulk
drugs and the final dosage forms are known as formulations. Bulk drugs are derived from
4 types of intermediates (raw material), namely :
• Plant derivatives (herbal products)
• Animal derivatives e.g. Insulin extracted from bovine pancreas.
• Synthetic Chemicals.
• Biogenetic (human) derivatives e.g. Human Insulin.
Doctors, post-diagnosis to cure a disease or disorder in the patient primarily prescribes
formulations. To prevent misuse/incorrect administration, most formulations are disbursed
by pharmacies only under medical prescription and these are called ethical products.

Indian Pharmaceutical Industry :

The Indian pharmaceutical industry is highly fragmented but has grown rapidly due to the
friendly patent regime and low cost manufacturing structure. Intense competition, high
volumes and low prices characterize the Indian domestic market. Exports have been rising
at around 30% CAGR over last five years. There is a shift in export profile towards value
added formulations from low value bulk drugs.
The Drug Pricing Control Order (DPCO) has been the millstone around the neck of Indian
industry as it has severally restricted profitability and hence innovation. However, the
 government has been relaxing controls in a slow but progressive manner. The span of
control of DPCO has come down as per the latest proposed changes.
In the domestic market, old and mature categories like anti-infectives, vitamins, analgesics
are degrowing or stagnating while new lifestyle categories like cardiovascular, CNS, anti
diabetic are growing at double-digit rates. The growth of a company in the domestic
market is thus critically dependent on its therapeutic presence.

Marketing of Pharmaceutical Industry in India:

The Indian Pharmaceutical Industry is a vibrant, high technology based and high growth
oriented industry - attracting attention the world over for its immense potential to produce
high quality drugs and pharmaceutical formulations. The Pharmaceutical Industry is
among the most highly R&D intensive industries. In fact, other than drug discovery,
marketing has been the most important function in the pharmaceutical industry.
The pharmaceutical marketing environment is perhaps the most challenging one on the
Indian industrial scene today. As it approaches a new millennium it is faced, on the one
hand, with new opportunities and new prospects, and on the other, with the emergence of a
radically ordered pharmaceutical order.
SWOT ANALYSIS

Pharma industry is a very important industry in all the over world and is the sales of medicine or
product delivery is so fast . pharma industries also operate throughout the united states as well as
in other competitive pharma industry .

STRENGTH :-

 Has network of all branches and advisor spread over towns in india having over
different advisor.
 Backed by yacca pharmaceuticals pvt. Ltd.
 Emphasis on production or satisfaction trough transport functioniong.
 Strong capital base .

WEAKNESS:-

 Some time low services due to transport inconvenience.

 Other competitor are always available in market .

OPPORTUNITY :-

 Growing potential in the market.

 Alignment with government schemes.
 Better awareness amongst people for getting insurance .

THREATS :-

 The competition of the pharma industry is very high .

 People are becoming much more aware of their health with this increase in
health awareness .
 A final treat is the increase of labor and medicine prices.
 OBJECTIVES OF THE STUDY

1. To know consumer’s satisfaction level towards medicine .

2. Build relationship with costomers
3. To gain consumer insights
4. Know about the medicine collection for the knowledge
5. How to providing customer services
6. How maintaining high standard of the chain of medicine delivery.
7. How to provide an excellent product to the customers
 RESERCH METHODOLOGY

RESEARCH DESIGN :-

I preferred pharma company as sample in Roorkee.

Describe research was adopted.

RESEARCH METHODS:-

I will prefer interview and filling of questionnaire to ensure and courage frank response to the
question. While framing the questionnaire I will try to list a series of question , which can provide
me the needed information . for study purpose I also keep isn mind the respondents understanding
capacity , ability to recall the information and his experience limits. I will not include those
questions which can have misconceptions and promote non-co-operation.

SOURCE OF DATA :-

Source of data is classified in to two categories :

a). Primary data

b). Secondary data

A) PRIMARY DATA :-

Primary data do not exist in records and publication .The researcher has to gather primary
data fresh for the specific study under taken by him. Market researcher are interested in
primary data about demographic / socio economic characteristics , attitude , opinions /
interests , motivation and behavior . three basic means of primary data :

1. Observation
2. Survey
3. Experiment
SECONDARY DATA

Exploratory research is often secondary research such as reviewing available data and
analyzing the current situation

Data is been extracted through secondary sources such as web , journals, relevant books
etc. In this research , company financials , charts and graphs are been extracted from
various web sources such as Equity masters. Money control , IBEF and stock exchange
websites.

METHOD OF DATA COLLECTION :

For getting the results of my reerch I used method which is questionnaire method that is under
primary data.

A questionnaire (also known as self-administered survey) is a type of statistical survey handed out
in paper to a demographic to gather gather information in order to provide better service or goods
Pharmaceutical Sector Analysis
 The Indian pharmaceuticals market (IPM ) accounts for approx. 1.4% of the global
pharmaceuticals industry in value terms and 10% in the volume terms . The IPM is
valued at Rs. 85 lacs for the year ending March 2018 . The growth in 2018 stood at
12.9% . owing to robust historical growth and future prospects , many MNC
companies have active presence in the Indian pharmaceuticals space .

 The IPM is highly Fragmented with about 1200 players ( 330 is organized sector ).
The market is dominated majorly by branded generics , which constitutes nearly
70% to 80% of market.

 The year gone by was one where M&A activity continued to attract interest of the

Companies globally . this included many indian names too. Indian companies such
as lupin , cipla , dr. reddy’s and other also showed keen interest. Lupin announced
a mega deal worth uss 800 m for acquiring gavis. On the other hand , Cipla and Dr.
Reddy’s too made acquisitions in the US and India respectively.
FUNDAMENTAL ANALYSIS
Fundamental analysis of a business involves analyzing its financial statement and health , its
management and competitive advantage , and its competitors and markets . when applied to future
and forex , it focuses on the overall state of the economy , interest rates , production , earnings ,
and management . when analyzing a stock , future contract , or currency using fundamental
analysis there are two basis approaches one can use ; bottom up analysis and top down analysis .
The term is used to distinguish such analysis from other type of investment analysis , such as
quantitative analysis and technical analysis .

Fundamental analysis is performed on historical and present data , but with the goal of making
financial forecasts . There are several possible objectives :

 To contract a company stock valuation and predict its probable price evolution
 To make a projection on its business performance.
 To evaluate its management and make internal business decision .
 To calculate its credit risk .

Fundamental analysis includes:

1. Economic analysis
2. Industry analysis
3. Company analysis

On the basis of this three analysis the intrinsic value of the shares are determined. This is
constructed as the true value of the share . if the intrinsic value is higher then the market price it is
recommended to buy the share but if is equal to market price hold the share and if it is less then
the market price sell the shares .

VALUATION OF STOCK :

We have considered only large cap stocks from pharma sector ( company having market
capitalization 500 crore rupees ) for investment purpose . Then we can decide whether stock is
undervalued based on sectorial P/E ration . is P/E ratio of the company is less then sectorial P/E
ratio , then stock is considered undervalued else it is overvalued.
VALUE PICKS:-

After valuation of stocks and bifurcating them into undervalued and overvalued stocks , to pick
value stocks we consider undervalued stocks only. Then we check whether EPS of these stock is
increased or not compared to last year performance . If EPS is increased , then we consider it as
value pick for portfolio.

From table , we can see that there is EPS growth for stocks Lupin , Cipla , Piramal enter, Torrent
Pharma , glen mark , Biocon , Ajanta pharma , Alembic pharma , Sanofi India hence we selected
them as value stocks .
LONG TERM PRICE TARGET:-

Long term price gives investor idea till which point he/she should hold the share. Long term price
Target is product of sectorial P/E of company . Sectorial P/E we have calculated in table . here in
the following table we have considered price considered market price .

So this gives investor a that which point they should sell the value stocks in which they invested
their money . Investors can calculate their approximate profit using and compare it with their
expectation . it gives rough idea whether the stock in which they are investing will fulfil their
expectation or not.
GROWTH PICKS :-

For selecting growth picks we consider overvalued stocks only. Then we calculate PEG ratio for
each stock . If PEG ratio is below 1 then we take it as growth stock in our portfolio.

So , from PEG Ratio calculations in above table we can see that for Pfizer PEG is below one so
ideally Pfizer should be selected as growth pick . But Natco Pharma has negative P/E hence it is
discarded, while stock of Abbott India have PEG more then 1 hence not considered in our growth
pick portfolio .
TECHNICAL ANALYSIS

Despite all the fancy and exotic tools , it employs , technical analysis reality just studies supply
and demand in a market in an attempt to determine what direction , or tend , will continue in the
future . In other words , technical analysis attempts to understand the emotions in the market by
studying the market itself , as opposed to its components . is you understand the benefits and
limitations of technical analysis , it can give you a new set of tools o skills that will enable you to
be a better trader or investor.

Technical analysis also extensively use indicators . which are typically mathematical
transformation of price of volume . These indicators are used to help determine whether an asset
is trending and if is . its price direction .

Technicians seek to forecast price movements such that large gains from successful trades exceed
more numerous but smaller losing trades , producing positive returns in the long run through
proper risk control and money management .

Technical Analysis is of two Types :

1. Short Term Analysis : Based on candle sticks

2. Long Term Analysis : Based on line graph
 LIMITATIONS OF THE STUDY

1. The study is limited only to pharmaceutical sector and only huge cap companies .

2. I have visited only 2 technical tools to predict the movement scripts.

3. Fundamental Analysis is used to analyze only financial performance of the companies.

4. Only technical analysis is used to predict the stock prices of the companies .
 RECOMMENDATION

Within the short term, pharma company should focus on making more efficient and availability
to their customers. This would help combat their tough competition as well as their declining
sales. The company can also focus on improving their online ordering procedures. In addition,
pharma company also improve their strategies of medicine delivery. In the long run, medicine
should focus on improving their customer base, which would increase their market share. They
could also look into making new products specific to the location of the store as well as adding
more variety to their menus with the changes and preferences of their customers.

 The pharma company to be competitive in market for their own establishment.

 The pharma company should increase its quality .
 The pharma company should provide good customer services and facility.
 The pharma company should reduce its charges .
 The pharma company have to expand its delivery area .
 pharma company should improve the quality of the medicine and increase the visibility in
the market, & Should try to regain the trust of the Customer services.
 CONCLUSION

Equity research is important for every investor in order to do investment . relative valuation model
is simplest method for fundamental analysis . Also, one can use long term and short term
technical analysis along with fundamental analysis . Calculating long term target price investor
can achieve
term and short term technical analysis along with fundamental analysis. Calculating long term
target price investor can achieve maximum profit and they also get an idea for how much
period they should hold the stock. Sectoral mutual fund of power sector and mutual fund
consisting of diverse sectors will give idea about how the mutual funds NAV are calculated
and their performance is analyzed with respect to market. If mutual fund is outperforming
market, it indicates that stocks selected in portfolio are good. From this report we can conclude
that by doing proper analysis of the stock and then investing in it would minimize the risk
involved in losing money in stocks. After all this analysis an investor can lose money because
at last the market behavior i.e. whether it is bullish or bearish depends on the buying and
selling of the stocks. At the end I want to conclude this project again by saying this that by
doing this analysis we would reduce risk in stock market it does not guarantee us that we will
not lose money.
 BIBLIOGRAPHY

 Mr. P.K. Bansal

 www.google.com
 info@yaccapharma.com
 www.yaccapharma.com.